MAVERICK CAPITAL LTD stakes above 5%
This list is built from 15 structured filings (Feb 14, 2025 to May 26, 2026). Structured (XML) filing became mandatory in December 2024, and 239 older filings are plain documents that are not read here. A stake whose latest report is one of those does not appear, so this can be an incomplete list.
Stakes above 5%
2
by the latest report on each company
Schedule 13D stakes
0
may want to influence the company
Reported 5% or less
6
latest report says so
Reports read
15
filed Feb 14, 2025 to May 26, 2026
Stakes above 5%
The latest report on each company. The change compares it with the report before it on the same company, when that one was read.
| Company | Report | Share of class | Shares | Since its previous report | Filed |
|---|---|---|---|---|---|
| Invivyd, Inc.Common Stock | Schedule 13G/A 3Passive investor (13d-1(c)) | 6.7% | 18,970,913 | -1.80 ptsfrom 8.5% | Feb 13, 2026event Dec 31, 2025 |
| Wave Life Sciences Ltd.$0 Par Value Ordinary Shares | Schedule 13G/A 3Passive investor (13d-1(c)) | 5.4% | 8,261,242 | no earlier report read | Feb 14, 2025event Dec 31, 2024 |
Reported 5% or less (6)
On these companies the latest report says the stake is 5% or less. That can mean it sold, and it can also mean the shares moved to a related entity, so it is not shown as a sale.
| Company | Report | What it says | Its previous report | Filed |
|---|---|---|---|---|
| Infleqtion, Inc.Common Stock | Schedule 13D/A 1 | Reports 3.6% | 9.2% on 2026-02-18 | May 26, 2026 |
| Peabody Energy CorporationCommon Stock | Schedule 13G/A 2 | Reports it no longer holds more than 5% | 6.7% on 2025-11-14 | Feb 13, 2026 |
| Rocket Pharmaceuticals, Inc.Common stock | Schedule 13G/A 2 | Reports it no longer holds more than 5% | 7.8% on 2025-08-14 | Feb 13, 2026 |
| Fractyl Health, Inc.Common Stock | Schedule 13G/A 1 | Reports it no longer holds more than 5% | not read | Nov 14, 2025 |
| Curis, Inc.Common Stock | Schedule 13G/A 4 | Reports it no longer holds more than 5% | 8% on 2025-02-14 | Nov 14, 2025 |
| Verona Pharma PlcOrdinary Shares | Schedule 13G/A 1 | Reports it no longer holds more than 5% | not read | Feb 14, 2025 |